The Relationship of Platelet Counts With Sickle Cell Anemia in the Eastern Region of Saudi Arabia
NCT06601894 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 650
Last updated 2024-10-04
Summary
This study aims to evaluate the relationship between platelet counts and sickle cell disease in the eastern region of the Kingdom of Saudi Arabia.
Conditions
- Sickle Cell Anaemia
- SCD
Interventions
- DIAGNOSTIC_TEST
-
Platelets count
the study include will take medical investigation data for all sickle cell patients.
Sponsors & Collaborators
-
Majmaah University
lead OTHER
Principal Investigators
-
Khalid A Majrashi · Majmaah University
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-03-30
- FDA Device
- Yes
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
NCT06158945 ·Status: RECRUITING
-
Study of Blood Platelets in Sickle Cell Disease
NCT00226083 ·Status: WITHDRAWN
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis
NCT03748043 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Exercise on Biomarkers in SCT
NCT04273022 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
COVID-19 Vaccine Response in Sickle Cell Disease
NCT05139992 ·Status: COMPLETED
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
NCT05660265 ·Status: TERMINATED ·Phase: PHASE1
-
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
NCT06385886 ·Status: RECRUITING
-
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787 ·Status: UNKNOWN
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
L-Glutamine Therapy for Sickle Cell Anemia
NCT00586209 ·Status: TERMINATED ·Phase: PHASE2
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)
NCT03068702 ·Status: COMPLETED
-
Transfusion Treatment in Patients With SCD
NCT03397017 ·Status: COMPLETED
-
Contraception in Women With Sickle Cell Disease
NCT02594462 ·Status: COMPLETED ·Phase: PHASE4
-
Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia
NCT05494333 ·Status: UNKNOWN
-
Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.
NCT06823219 ·Status: RECRUITING ·Phase: NA
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia
NCT05883254 ·Status: NOT_YET_RECRUITING
-
Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
NCT01888614 ·Status: WITHDRAWN
-
Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia:
NCT03368924 ·Status: COMPLETED ·Phase: NA
-
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
NCT01179217 ·Status: COMPLETED ·Phase: PHASE3